The deal size was increased to $198M in common stock from $175M in common stock. Goldman Sachs, Stifel, Wedbush and Baird acted as joint book running managers for the offering.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GERN:
- Geron announces $175M common stock offering
- GERN Surges after Phase 3 Clinical Trial Data
- Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
- Geron reports ‘positive’ results from IMerge Phase 3 trial of imetelstat
- TipRanks ‘Perfect 10’ List: 2 Stocks Under $5 That Are Worth Looking Into
